Amanda Eilian has been actively investing in early stage consumer companies for the last decade, drawing on her experience as an institutional investor and entrepreneur. Her focus today is on companies that make the daily lives of consumers healthier, happier, and more meaningful. In this episode, Amanda and Paul discuss narrowing the wellness gap and investing in psychedelics for long-term solutions to mental illness.